COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.4 | 2 | 0057-0222 | 369.13 | 222.56 | 396 | 74.43 | 0.898 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 341.2 | 2 | 0058-0220 | 809.97 | 219.30 | 252 | 61.84 | 0.828 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.9 | 2 | 0059-0225 | 138.35 | 225.82 | 377 | 76.33 | 0.813 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 239.8 | 2 | 0060-0225 | 744.58 | 224.81 | 387 | 72.43 | 0.927 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 457.0 | 2 | 0061-0227 | 215.53 | 227.48 | 439 | 82.67 | 0.807 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 254.7 | 2 | 0062-0227 | 794.99 | 228.06 | 380 | 80.18 | 0.743 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 296.6 | 2 | 0063-0238 | 563.83 | 238.32 | 597 | 91.26 | 0.901 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 268.6 | 2 | 0064-0234 | 268.82 | 234.46 | 438 | 79.01 | 0.882 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.9 | 2 | 0065-0248 | 329.53 | 248.37 | 391 | 74.43 | 0.887 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 193.3 | 2 | 0066-0248 | 76.01 | 248.58 | 386 | 72.43 | 0.925 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 227.1 | 2 | 0067-0258 | 791.77 | 257.78 | 926 | 128.23 | 0.708 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 872.2 | 2 | 0068-0251 | 221.60 | 250.53 | 395 | 78.67 | 0.802 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.3 | 2 | 0069-0251 | 679.71 | 251.58 | 412 | 75.01 | 0.920 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 242.1 | 2 | 0070-0256 | 913.82 | 256.63 | 581 | 89.50 | 0.912 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 232.4 | 2 | 0071-0260 | 634.98 | 259.87 | 382 | 72.77 | 0.907 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 214.1 | 2 | 0072-0266 | 169.77 | 266.61 | 555 | 96.23 | 0.753 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 198.4 | 2 | 0073-0264 | 451.20 | 264.72 | 414 | 76.67 | 0.885 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 290.1 | 2 | 0074-0266 | 525.51 | 266.37 | 435 | 83.74 | 0.780 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 241.2 | 2 | 0075-0274 | 371.77 | 274.85 | 796 | 111.64 | 0.803 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 242.8 | 2 | 0076-0271 | 411.01 | 271.76 | 403 | 74.67 | 0.908 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 290.1 | 2 | 0077-0270 | 500.82 | 269.96 | 400 | 77.01 | 0.848 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 254.8 | 2 | 0078-0293 | 308.49 | 292.92 | 419 | 77.84 | 0.869 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 222.8 | 2 | 0079-0294 | 470.07 | 294.22 | 400 | 77.50 | 0.837 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 229.2 | 2 | 0080-0297 | 67.35 | 297.65 | 383 | 73.84 | 0.883 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 240.9 | 2 | 0081-0302 | 901.77 | 302.16 | 369 | 72.87 | 0.873 |